{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:58:24Z","timestamp":1761314304111,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03778-4","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:54:08Z","timestamp":1761314048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic and immunological characterization of elderly acute myeloid leukemia evaluated by butyrate metabolism-related genes"],"prefix":"10.1007","volume":"16","author":[{"given":"Yiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"3778_CR1","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41375-023-01999-6","volume":"37","author":"E Jahn","year":"2023","unstructured":"Jahn E, et al. Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia. 2023;37:2187\u201396.","journal-title":"Leukemia"},{"key":"3778_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"key":"3778_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1182\/blood.2022015832","volume":"140","author":"AM Zeidan","year":"2022","unstructured":"Zeidan AM, et al. Prospective comparison of outcomes with Azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy. Blood. 2022;140:285\u20139.","journal-title":"Blood"},{"key":"3778_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","volume":"133","author":"CD DiNardo","year":"2019","unstructured":"DiNardo CD, et al. Venetoclax combined with decitabine or Azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019;133:7\u201317.","journal-title":"Blood"},{"key":"3778_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","volume":"386","author":"P Montesinos","year":"2022","unstructured":"Montesinos P, et al. Ivosidenib and Azacitidine in IDH1-Mutated acute myeloid leukemia. N Engl J Med. 2022;386:1519\u201331.","journal-title":"N Engl J Med"},{"key":"3778_CR6","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1016\/S2352-3026(23)00273-9","volume":"10","author":"M Lubbert","year":"2023","unstructured":"Lubbert M, et al. 10-day decitabine versus 3\u2009+\u20097 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. Lancet Haematol. 2023;10:e879\u201389.","journal-title":"Lancet Haematol"},{"issue":"12","key":"3778_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrgastro.2016.165","volume":"13","author":"SJ O\u2019Keefe","year":"2016","unstructured":"O\u2019Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 2016;13(12):691\u2013706.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3778_CR8","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1038\/s41598-023-32457-z","volume":"13","author":"Q Luo","year":"2023","unstructured":"Luo Q, Zhou P, Chang S, et al. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment. Sci Rep. 2023;13(1):5106.","journal-title":"Sci Rep"},{"issue":"10","key":"3778_CR9","doi-asserted-by":"publisher","first-page":"113197","DOI":"10.1016\/j.celrep.2023.113197","volume":"42","author":"S Liu","year":"2023","unstructured":"Liu S, Wu R, Chen L, et al. CPSF6 regulates alternative polyadenylation and proliferation of cancer cells through phase separation. Cell Rep. 2023;42(10):113197.","journal-title":"Cell Rep"},{"issue":"1","key":"3778_CR10","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1038\/s41467-022-30240-8","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Yang X, Liu J, et al. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022;13(1):2522.","journal-title":"Nat Commun"},{"key":"3778_CR11","doi-asserted-by":"publisher","first-page":"137499","DOI":"10.1016\/j.chemosphere.2022.137499","volume":"313","author":"J Wang","year":"2023","unstructured":"Wang J, Han L, Liu Z, et al. Genus unclassified_Muribaculaceae and microbiota-derived butyrate and indole-3-propionic acid are involved in benzene-induced hematopoietic injury in mice. Chemosphere. 2023;313:137499.","journal-title":"Chemosphere"},{"issue":"3","key":"3778_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/antiox11030461","volume":"11","author":"HA Alkhatabi","year":"2022","unstructured":"Alkhatabi HA, Zohny SF, Shait Mohammed MR, et al. Venetoclax-Resistant MV4-11 leukemic cells activate PI3K\/AKT pathway for metabolic reprogramming and redox adaptation for survival. Antioxid (Basel). 2022;11(3):461.","journal-title":"Antioxid (Basel)"},{"key":"3778_CR13","doi-asserted-by":"publisher","first-page":"950213","DOI":"10.3389\/fimmu.2022.950213","volume":"13","author":"X Lou","year":"2022","unstructured":"Lou X, Zhao K, Xu J, et al. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment. Front Immunol. 2022;13:950213.","journal-title":"Front Immunol"},{"issue":"9","key":"3778_CR14","doi-asserted-by":"publisher","first-page":"e19342","DOI":"10.1016\/j.heliyon.2023.e19342","volume":"9","author":"L Sheng","year":"2023","unstructured":"Sheng L, Li T, Li Y, et al. Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features. Heliyon. 2023;9(9):e19342.","journal-title":"Heliyon"},{"key":"3778_CR15","doi-asserted-by":"publisher","first-page":"1166668","DOI":"10.3389\/fgene.2023.1166668","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Wang K. Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer. Front Genet. 2023;14:1166668.","journal-title":"Front Genet"},{"key":"3778_CR16","doi-asserted-by":"crossref","unstructured":"Lai C, Wu Z, Li Z et al. Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer. Clin Transl Oncol. 2023.","DOI":"10.21203\/rs.3.rs-3298491\/v1"},{"issue":"18","key":"3778_CR17","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.18632\/aging.204888","volume":"15","author":"D Feng","year":"2023","unstructured":"Feng D, Li L, Shi X, et al. Identification of senescence-related LncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients. Aging. 2023;15(18):9358\u201376.","journal-title":"Aging"},{"issue":"1","key":"3778_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12967-022-03656-5","volume":"20","author":"R Zhang","year":"2022","unstructured":"Zhang R, Liu F. Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. J Transl Med. 2022;20(1):453.","journal-title":"J Transl Med"},{"issue":"50","key":"3778_CR19","doi-asserted-by":"publisher","first-page":"e31290","DOI":"10.1097\/MD.0000000000031290","volume":"101","author":"X Zhuo","year":"2022","unstructured":"Zhuo X, Dai H, Yu S. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma. Med (Baltim). 2022;101(50):e31290.","journal-title":"Med (Baltim)"},{"issue":"4","key":"3778_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/bjc.2017.442","volume":"118","author":"H Ma","year":"2018","unstructured":"Ma H, Jin S, Yang W, et al. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma. Br J Cancer. 2018;118(4):509\u201321.","journal-title":"Br J Cancer"},{"issue":"6","key":"3778_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/17474086.2020.1758058","volume":"13","author":"X Thomas","year":"2020","unstructured":"Thomas X, Elhamri M, Heiblig M. Emerging pharmacotherapies for elderly acute myeloid leukemia patients. Expert Rev Hematol. 2020;13(6):619\u201343.","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"3778_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.immuni.2024.01.002","volume":"57","author":"EM Eshleman","year":"2024","unstructured":"Eshleman EM, Rice T, Potter C, et al. Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity. Immunity. 2024;57(2):319\u2013e3326.","journal-title":"Immunity"},{"issue":"1","key":"3778_CR23","doi-asserted-by":"publisher","first-page":"2363020","DOI":"10.1080\/19490976.2024.2363020","volume":"16","author":"W Yang","year":"2024","unstructured":"Yang W, Yu T, Liu X, et al. Microbial metabolite butyrate modulates granzyme B in tolerogenic IL-10 producing Th1 cells to regulate intestinal inflammation. Gut Microbes. 2024;16(1):2363020.","journal-title":"Gut Microbes"},{"issue":"3","key":"3778_CR24","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1002\/imt2.70024","volume":"4","author":"J Shi","year":"2025","unstructured":"Shi J, Mao W, Song Y, et al. Butyrate alleviates food allergy by improving intestinal barrier integrity through suppressing oxidative stress-mediated Notch signaling. Imeta. 2025;4(3):e70024.","journal-title":"Imeta"},{"issue":"10","key":"3778_CR25","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.7150\/jca.113136","volume":"16","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Li B, Li P. Prognostic implications and immune landscape analysis of Necroptosis-associated gene signatures in acute myeloid leukemia. J Cancer. 2025;16(10):3202\u201315.","journal-title":"J Cancer"},{"issue":"1","key":"3778_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bjh.18773","volume":"203","author":"A Roeser","year":"2023","unstructured":"Roeser A, Lazarus AH, Mah\u00e9vas M. B cells and antibodies in refractory immune thrombocytopenia. Br J Haematol. 2023;203(1):43\u201353.","journal-title":"Br J Haematol"},{"key":"3778_CR27","doi-asserted-by":"publisher","first-page":"882018","DOI":"10.3389\/fonc.2022.882018","volume":"12","author":"P Tu","year":"2022","unstructured":"Tu P, Li X, Cao L, et al. Machine learning and BP neural network revealed abnormal B cell infiltration predicts the survival of lung cancer patients. Front Oncol. 2022;12:882018.","journal-title":"Front Oncol"},{"issue":"1","key":"3778_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12967-023-04582-w","volume":"21","author":"X Zhou","year":"2023","unstructured":"Zhou X, You L, Xin Z, et al. Leveraging Circulating Microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer. J Transl Med. 2023;21(1):800.","journal-title":"J Transl Med"},{"key":"3778_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejca.2023.02.012","volume":"185","author":"M Backman","year":"2023","unstructured":"Backman M, Strell C, Lindberg A, et al. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer. Eur J Cancer. 2023;185:40\u201352.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3778_CR30","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","volume":"15","author":"L Kasikova","year":"2024","unstructured":"Kasikova L, Rakova J, Hensler M, et al. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer. Nat Commun. 2024;15(1):2528.","journal-title":"Nat Commun"},{"issue":"7632","key":"3778_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature20165","volume":"540","author":"PA Tyrakis","year":"2016","unstructured":"Tyrakis PA, Palazon A, Macias D, et al. S-2-hydroxyglutarate regulates CD8\u2009+\u2009T-lymphocyte fate. Nature. 2016;540(7632):236\u201341.","journal-title":"Nature"},{"issue":"1","key":"3778_CR32","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1038\/s41467-021-26282-z","volume":"12","author":"HA Abbas","year":"2021","unstructured":"Abbas HA, Hao D, Tomczak K, et al. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 Blockade therapy. Nat Commun. 2021;12(1):6071.","journal-title":"Nat Commun"},{"issue":"19","key":"3778_CR33","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1182\/blood.2020009192","volume":"138","author":"H Jetani","year":"2021","unstructured":"Jetani H, Navarro-Bail\u00f3n A, Maucher M, et al. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia. Blood. 2021;138(19):1830\u201342.","journal-title":"Blood"},{"issue":"1","key":"3778_CR34","doi-asserted-by":"publisher","first-page":"166685","DOI":"10.1016\/j.jmb.2020.10.019","volume":"433","author":"M Horii","year":"2021","unstructured":"Horii M, Matsushita T. Regulatory B cells and T cell regulation in cancer. J Mol Biol. 2021;433(1):166685.","journal-title":"J Mol Biol"},{"issue":"12","key":"3778_CR35","doi-asserted-by":"publisher","first-page":"e202302156","DOI":"10.26508\/lsa.202302156","volume":"6","author":"N Gautam","year":"2023","unstructured":"Gautam N, Wojciech L, Yap J, et al. Themis controls T cell activation, effector functions, and metabolism of peripheral CD8\u2009+\u2009T cells. Life Sci Alliance. 2023;6(12):e202302156.","journal-title":"Life Sci Alliance"},{"key":"3778_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2024.09.001","volume":"288\u2013289","author":"L Jahangiri","year":"2024","unstructured":"Jahangiri L. Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment. Cancer Genet. 2024;288\u2013289:32\u20139.","journal-title":"Cancer Genet"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03778-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:54:09Z","timestamp":1761314049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03778-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03778-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1965"}}